SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?


To: Jorj X Mckie who wrote (42990)6/26/2003 1:01:26 PM
From: scotty  Respond to of 57110
 
Interesting development....Background, Medgenn has developed YH-16 medgenn.com YH-16 was chosen as first drug to be tested in clinical trials in China...http://www.china.org.cn/english/2002/Sep/43169.htm ....now this..http://ragingbull.lycos.com/mboard/boards.cgi?board=ENMD&read=47759 I'm playing via ENMD, endostatin and YH-16 are similar



To: Jorj X Mckie who wrote (42990)6/26/2003 1:43:26 PM
From: stevenallen  Read Replies (1) | Respond to of 57110
 
<<DAL might want 16.00 or even a little higher>>
If that happens I load up the truck